ENTITY
TYK Medicines

TYK Medicines (2410 HK)

47
Analysis
Health Care • China
TYK Medicines is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of small molecule pharmaceutical products. The company's pipeline includes drug candidates for treating various cancers, such as breast cancer, prostate cancer, and solid tumors. TYK Medicines was founded in 2017 and is headquartered in Huzhou, China.
more
Exchange Announcement • 30 Sep 2026 16:44

Form Of Proxy For The Second Extraordinary General Meeting Of 2026 To Be Held On Friday, October 16, 2026 And Any Adjournment Thereof

Exchange Announcement • 30 Sep 2026 16:43

Notice Of The Second Extraordinary General Meeting Of 2026

Exchange Announcement • 30 Sep 2026 16:41

(1) Re-Election Of The Retiring Directors; (2) Proposed Amendments To The Articles Of Association; And (3) Notice Of The Second Extraordinary General Meeting Of 2026

Exchange Announcement • 20 Sep 2026 19:03

Lapse Of Subscription Agreement In Relation To The Issue Of H Shares Under General Mandate

Exchange Announcement • 18 Sep 2026 16:31

Book Closure Period For 2026 Second Extraordinary General Meeting

x